![Sui Xiong Cai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sui Xiong Cai
Directeur Général chez
IMPACT THERAPEUTICS, INC
Fortune : 14 M $ au 31/07/2026
Profil
Sui Xiong Cai is currently Chief Executive Officer & Executive Director at IMPACT Therapeutics, Inc., a position started in 2025.
Formerly, Dr. Cai was Senior Director-Chemistry at EpiCept Corp.
from 2006 to 2009.
Education includes a doctorate from the University of Oregon, conferred in 1990.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 8 422 233 ( 2,98 % ) | 14 M $ | 31/07/2026 |
Postes actifs de Sui Xiong Cai
| Sociétés | Poste | Début |
|---|---|---|
| IMPACT THERAPEUTICS, INC | Directeur Général | 01/06/2014 |
Anciens postes connus de Sui Xiong Cai
| Sociétés | Poste | Fin |
|---|---|---|
EpiCept Corp.
 EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Corporate Officer/Principal | 01/01/2009 |
Formation de Sui Xiong Cai
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
IMPACT Therapeutics, Inc.
 IMPACT Therapeutics, Inc. BiotechnologyHealth Technology Operates as a commercial-stage biotechnology company that develops anti-cancer therapies and pharmaceutical products | Health Technology |
